Bratislava, Slovakia

Olga Caletkova

This inventor holds 1 USPTO granted patent. Top assignees: Institute of Organic Chemistry and Biochemistry, Palacký University in Olomouc. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olga Caletkova. Retrieved from https://idiyas.com/inventor/olga-caletkova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Olga Caletkova

Introduction

Olga Caletkova is a notable inventor based in Bratislava, Slovakia. She has made significant contributions to the field of organic chemistry, particularly in the development of therapeutic compounds. Her work has implications for various medical applications, showcasing her expertise and dedication to innovation.

Latest Patents

Olga Caletkova holds a patent for "Substituted 7-deazapurine ribonucleosides for therapeutic uses." This patent includes compounds of Formula I and a pharmaceutically acceptable salt thereof, as well as an optical isomer or a mixture of optical isomers. The patent also covers compositions that include such compounds and therapeutic methods that utilize them.

Career Highlights

Throughout her career, Caletkova has worked with esteemed institutions such as the Institute of Organic Chemistry and Biochemistry ASCR and Palacký University in Olomouc. Her experience in these organizations has allowed her to advance her research and contribute to the scientific community.

Collaborations

Olga has collaborated with notable colleagues, including Michal Hocek and Petr Naus. These partnerships have enriched her research and expanded the impact of her work in the field of organic chemistry.

Conclusion

Olga Caletkova's innovative work and patent contributions highlight her role as a significant figure in the realm of therapeutic compounds. Her dedication to research and collaboration continues to influence the scientific community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…